2021 News Release
-
Fiscal 2022 Reform of the NHI Drug Price System
-
The 15th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry
-
Announcement of the Pharmaceutical Association of Japan Code of Practice "Month for Promoting Understanding of the Code
-
Establishment of "List of Non-Financial Information Disclosure" (links) for member companies of the Pharmaceutical Manufacturers Association of Japan (PMAJ)
-
Disciplinary Action Taken Against Member Companies
-
Following the release of the "Pharmaceutical Industry Vision 2021
-
Renewal of the website of the Pharmaceutical Manufacturers Association of Japan (PAPJ)
〜 New website to strengthen information dissemination, to make it easier to use and to reach the industry's voice -
Disciplinary Action Taken Against Member Companies
-
Press Conference by the Chairman of the Pharmaceutical Manufacturers Association of Japan held on May 20
-
On "The Pharmaceutical Manufacturers Association of Japan Industry Vision 2025 Supplementary Edition
-
Notice on Election of New Board Members
-
Abandonment of Intellectual Property in the WTO
-
The 10th Asian Pharmaceutical Association Conference (APAC)
-
10th Asian Pharmaceutical Association Conference (APAC) Press Conference on April 14
-
Material for the March 23 press conference by the Chairman of the Pharmaceutical Manufacturers Association of Japan
-
The National Center Biobank Network and the member companies of the Japan Pharmaceutical Manufacturers Association (JPMA) started industry-academia-government collaboration on the construction and utilization of an integrated database of disease-specific information
Toward Early Implementation of Precision Medicine, Prevention, and Preemptive Medicine -
Efforts to Countermeasure New Coronavirus Infection
In response to the declaration of a state of emergency